Zydus Wellness Share Price Jumps 16% Despite Weak Market

Zydus Wellness share price (NSE: ZYDUSWELL) surged sharply on Friday, rising as much as 16% during intraday trade even as the broader market remained weak. The stock has been gaining for the fourth straight trading session, with a total rise of about 20% during this period.
Zydus Wellness Share Price Movement
During Friday’s session, the stock climbed to an intraday high of ₹450 on the Bombay Stock Exchange.
By around 1:37 PM, the stock was trading near ₹438, up about 13%, while the BSE Sensex was down nearly 2%.
Strong Brand Portfolio
Zydus Wellness Limited is a consumer health and wellness company with several well-known brands in its portfolio, including:
- Sugar Free
- Glucon-D
- Nutralite
- Everyuth
- Nycil
- Complan
- RiteBite Max Protein
These brands have helped the company build a strong position in India’s health and wellness product market.
Zydus Wellness Q3 Financial Performance
For the third quarter of FY26, Zydus Wellness Limited reported strong growth in revenue and operating profit.
- Net Sales: ₹963.3 crore (up 113.7% YoY)
- EBITDA: ₹61 crore (up 312% YoY)
The growth was partly supported by the integration of the newly acquired Comfort Click business.
The company’s gross margin expanded to 63.4%, rising sharply due to a shift toward higher-margin wellness products.
Growth in Key Businesses
The company’s Sugar Free brand maintained its leadership in the sugar substitute category with a 96.3% market share.
Other developments include:
- Sugar Free Green recorded double-digit growth for 19 consecutive quarters.
- The RiteBite Max Protein business has doubled in size, exceeding company expectations.
Demand was also supported by strong rural consumption and growth in quick commerce and e-commerce channels.
Read More: Centre Directs States to Prevent LPG Hoarding and Panic Buying Amid Supply Concerns.
Conclusion
Shares of Zydus Wellness Limited surged strongly despite a weak market, driven by heavy trading volumes and improved quarterly performance.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Mar 13, 2026, 3:47 PM IST

Kusum Kumari
- RPG Life Sciences Share Price Crashes Over 10% After Q2 FY27 Results
- ACME Solar Share in Focus as Subsidiary Collaborates with NTPC on 400 MW Renewable Energy Project
- Hikal Share Price Gains Over 8%; Achieves Swissmedic GMP Certification for Bengaluru Facility
- Sun Pharma Share Price Gains Nearly 2%; Secures FDA Approval for ILUMYA in Treating Psoriatic Arthritis
- Best Long-Term Stocks in November 2026 Based on 5 Year CAGR: BSE, Adani Power and More




